Ken Biolinks Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 21 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.98 Cr
as on 24-10-2024
- Revenue 19.07%
(FY 2023)
- Profit -56.62%
(FY 2023)
- Ebitda 6.90%
(FY 2023)
- Net Worth 11.77%
(FY 2023)
- Total Assets -3.72%
(FY 2023)
About Ken Biolinks
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.98 Cr.
Kothanadam Srinivasan, Pushparani Sankarraman, and Kutralanathan Alangaranathan serve as directors at the Company.
- CIN/LLPIN
U90001TN2003PTC050548
- Company No.
050548
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ken Biolinks?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kothanadam Srinivasan  | Director | 20-Mar-2003 | Current |
| Pushparani Sankarraman | Director | 31-Aug-2007 | Current |
| Kutralanathan Alangaranathan | Director | 29-Mar-2003 | Current |
Financial Performance of Ken Biolinks.
Ken Biolinks Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.07% increase. The company also saw a substantial fall in profitability, with a 56.62% decrease in profit. The company's net worth Soared by an impressive increase of 11.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ken Biolinks?
In 2023, Ken Biolinks had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ensys Technologies India Private LimitedActive 28 years 17 daysPushparani Sankarraman and Kutralanathan Alangaranathan are mutual person
Koushic Pressure Vessels Private LimitedActive 25 years 8 monthsKothanadam Srinivasan is a mutual person
- Aem Ocean Technologies And Services Private LimitedActive 20 years 4 months
Kothanadam Srinivasan is a mutual person
- Vibrant Speciality Plasto LlpActive 6 years 10 months
Kutralanathan Alangaranathan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The South Indian Bank Limited Creation Date: 23 Aug 2022 | ₹1.35 M | Open |
Others Creation Date: 24 Mar 2022 | ₹1.00 Cr | Open |
Others Creation Date: 16 Feb 2022 | ₹0.90 M | Open |
How Many Employees Work at Ken Biolinks?
Ken Biolinks has a workforce of 18 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ken Biolinks, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ken Biolinks's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
